M&A Deal Summary

Cipher Pharmaceuticals Acquires Innocutis Medical

On April 13, 2015, Cipher Pharmaceuticals acquired medical products company Innocutis Medical from Ballast Point Ventures for 46M USD

Acquisition Highlights
  • This is Cipher Pharmaceuticals’ 1st transaction in the Medical Products sector.
  • This is Cipher Pharmaceuticals’ largest (disclosed) transaction.
  • This is Cipher Pharmaceuticals’ 2nd transaction in the United States.
  • This is Cipher Pharmaceuticals’ 1st transaction in South Carolina.

M&A Deal Summary
Date 2015-04-13
Target Innocutis Medical
Sector Medical Products
Buyer(s) Cipher Pharmaceuticals
Sellers(s) Ballast Point Ventures
Deal Type Add-on Acquisition
Deal Value 46M USD

Target

Innocutis Medical

Charleston, South Carolina, United States
Innocutis Medical LLC is a Specialty pharmaceutical company providing branded prescription products and surgical devices to office-based dermatologists.

Search 198,242 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Cipher Pharmaceuticals

Mississauga, Ontario, Canada
Category Company
Founded 2000
Sector Life Science
Employees5
Revenue 21M USD (2023)
DESCRIPTION

Cipher Pharmaceuticals is a specialty pharmaceutical company focused on dermatology. Cipher acquires products that fulfill high unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly or through partners. Cipher Pharmaceuticals was founded in 2000 and is based in Mississauga, Ontario.

DEAL STATS #
Overall 2 of 2
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 2 of 2
State (South Carolina) 1 of 1
Country (United States) 2 of 2
Year (2015) 2 of 2
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-01-09 Melanovus Oncology

Hummelstown, Pennsylvania, United States

Melanovus Oncology Inc. is a life sciences company. Melanovus acquired an exclusive global license to a library of compounds and related intellectual property from the Penn State Research Foundation.

Buy -

Seller(S) 1

SELLER

Ballast Point Ventures

Tampa, Florida, United States

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 2001
PE ASSETS 550M USD
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Ballast Point Ventures is a private investment firm that targets growth businesses located in the South US. Ballast Point looks to commit $1 to $5 million of equity capital per transaction and looks for businesses in markets with annual revenues of at least $100 million. Sectors of interest include healthcare, information technology (IT), financial services, communications, business services, and consumer products/services. Ballast Point Ventures was formed in 2001 and is based in St. Petersburg, Florida.

DEAL STATS #
Overall 28 of 32
Sector (Medical Products) 2 of 2
Type (Add-on Acquisition) 11 of 12
State (South Carolina) 1 of 1
Country (United States) 28 of 32
Year (2015) 3 of 3
Size (of disclosed) 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-03-31 KBI Biopharma

Durham, North Carolina, United States

KBI Biopharma, Inc. is a contract biopharmaceutical development, enhancing drug value by bringing products to market more rapidly and efficiently.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-01 Dash Solutions

Homewood, Alabama, United States

Dash Solutions provides electronic payment solutions including payroll, expense, gift, reward and incentive card products to employers, financial institutions, and government agencies. Dash Solutions was founded in 1998 and is based in Homewood, Alabama.

Buy -
Mergr

Product

Company

Legal